Abstract 13948: Patterns of Prescribing Sodium-Glucose Cotransporter-2 Inhibitors for Medicare Beneficiaries in the United States

Background: Evidence from large randomized clinical trials supports the benefit of SGLT2is to improve cardiovascular and kidney outcomes in patients with type 2 diabetes mellitus (T2DM). In light o...